Enliven: Immunology and Immunotechniques

Augmentation of Lipopolysaccharide (lps) Receptor Expression by Interferon y Correlates with Susceptibility to lps-Induced Apoptosis in Human Monoblastic Cell Line u937
General Information

Taku Kuwabara1,* and Shinobu Imajoh-Ohmi2,*

1Department of Basic Medical Science, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

2Shinobu Imajoh-Ohmi, Department of Basic Medical Sciences, The Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan, Tel: +81-3-5449-5311; Fax: +81-3-5449-5491; E-mail: ohmi@ims.u-tokyo.ac.jp

Corresponding author

Taku Kuwabara, Department of Basic Medical Sciences, The Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan, Tel: +81-3-5449-5311; Fax: +81-3-5449-5491; E-mail: kuwabara@ims.u-tokyo.ac.jp


Received Date: 15thNovember 2014

Accepted Date: 06th December 2014

Published Date: 08th December 2014


Kuwabara T,Imajoh-Ohmi S (2014) Augmentation of Lipopolysaccharide (lps) Receptor Expression by Interferon g Correlates with Susceptibility to lps-Induced Apoptosis in Human Monoblastic Cell Line u937. Enliven: Immunol Immunotechnol 1(1): 002


@ 2014 Taku Kuwabara .This is an Open Access article published and distributed under the terms of the Creative Commons Attribution License, that permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.


Apoptosis, accompanied with cytoplasmic shrinkage, nuclear condensation and caspase activation induced by LPS, is thought to proceed via activation of LPS receptor, which is comprised of the toll-like receptor (TLR) 4 and MD-2. We report that LPS induced apoptosis in the human monoblastic cell line U937 that was pretreated with interferon γ(U937IFN), but not in cells that were untreated or treated with retinoic acid (U937RA). To reveal the reason why interferon LipoPolySaccharide (LPS); Apoptosis; LPS receptor; Differentiation; Monocyte LipoPolySaccharide (LPS); Apoptosis; LPS receptor; Differentiation; Monocyte γ(IFN) confers apoptotic susceptibility to U937 cells, we focused on the LPS receptor. IFN stimulated the expression of cell surface TLR4 and the transcription level of MD-2 mRNA. By transfecting a designed antisense oligonucleotide (ASO) into U937IFN cells before exposing to LPS, the expression level of TLR4 was lowered to levels comparable to those in U937 cells; ASO transfected-cells showed no cleavage of poly (ADP-ribose) polymerase (PARP) and exhibited no morphological changes. Addition of an anti-TLR4 monoclonal antibody to the cultures of U937IFN cells along with LPS resulted in reduction of the Ac-DEVD-MCA hydrolysis and inhibition of the PARP cleavage. Neither a loss of function form of FADD, an adaptor molecule for death receptor signaling, nor a neutralization antibody against TNF-α or Fas prevented LPS-triggered apoptosis, indicating that the death ligand and death receptor were not activated. These results suggest that IFN induces expression of the LPS receptor, resulting in increased susceptibility to LPS-induced apoptosis.



LipoPolySaccharide (LPS); Apoptosis; LPS receptor; Differentiation; Monocyte


Cells acquire various functions and change their activities in response to various extracellular agents that induce or suppress cellular proteins. Some of these agents also trigger increased or decreased expression level of apoptotic molecules, resulting in changes in apoptotic susceptibility. Kikuchi, et al. previously reported that human monoblastic cell line U937 differentiates into CD11b-positive monocyte/macrophage-like cells upon treatment with interferon γ (IFN) or all-trans retinoic acid (RA), and that its susceptibility to Fas- and tumor necrosis factor (TNF)-mediated apoptosis changes ; IFN-treated cells become highly susceptible, whereas RA-treated cells become Fas-resistant [1]. Other researcher has reported that RA decreases apoptotic susceptibility to Fas because this reagent reduces expression of Fas on the U937 cell surface [2]. On the other hand, IFN results in accumulation of Fas on the cell surface, and consequently the large number of Fas molecules contributes to increased apoptotic sensitivity [3,4]. Caspase-8, which is activated at the cytoplasmic domain of Fas, is also induced by IFN and promotes a state of susceptibility to apoptosis [5].


IFN-pretreated U937 cells (U937IFN) infected in vitro with Shigella flexneri undergo nuclear fragmentation and digestion of poly (ADP-ribose) polymerase (PARP), typical apoptotic properties [6]. Recently, it was found that dead bacterial bodies or avirulent Shigella strains also induce apoptosis in U937IFN cells [7]. Undifferentiated U937 cells or RA-pretreated cells (U937RA) did not show this virulence-independent apoptosis. It is conceivable that U937IFN cells acquired apoptotic sensitivity to infectious stimuli and those apoptosis-inducing elements in bacteria are independent of virulence proteins, cell invasion and intracellular propagation. Quite recently, we reported that lipopolysaccharide (LPS), one of bacterial cell surface components, induces apoptosis to U937IFN cells (Kuwabara and Imajoh-Ohmi, submitted). The LPS receptor consists of TLR4 and MD-2, and induces apoptosis in mammalian cells. However, the relationship between the LPS receptor and IFN-dependent susceptibility to LPS-induced apoptosis is still unknown.


In this study, we investigated whether IFN enhances the amount of LPS receptor on the cell surface and whether the sensitivity of LPS-induced apoptosis depends on the expression level of the LPS receptor. Expression levels of TLR4 and MD-2 were compared between U937, U937IFN and U937RA cells. Neutralization by an anti-TLR4 antibody, and knock down of expression by an antisense oligonucleotide (ASO), were examined. We also tested whether LPS-induced apoptosis activates the death receptor and its ligand. U937IFN cells, but not U937 cells or U937RA cells, exhibited LPS-mediated apoptosis. The amount of TLR4 on the cell surface and the mRNA level of MD-2 were increased by IFN treatment. In the presence of the anti-TLR4 antibody, LPS failed to activate caspase. When TLR4 on the surface of U937IFN cells was decreased by ASO, LPS-induced apoptosis was prevented. LPS did not affect the death receptor and ligand. Our results suggest that an apoptotic susceptibility shift accompanying cell differentiation closely relates to the expression level of the LPS receptor.

Materials and Methods


3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), LPS (Shigella flexneri serotype 1A), RA, and Rhodamine123 were obtained from Sigma Aldrich Japan (Tokyo, Japan). Recombinant human interferon-? (IFN) was kindly provided by Shionogi Pharmaceuticals (Osaka, Japan). An anti-TLR4 monoclonal antibody (MoAb), an anti-FADD MoAb and two anti-Fas MoAbs (CH-11 for the cytotoxic assay and ZB4 for the neutralization assay) were purchased from MBL (Nagoya, Japan). The anti-human TNF-α antibody was purchased from R & D systems (Minneapolis, MN, USA). Carbobenzoxy-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk) and acetyl-Asp-Glu-Val-Asp-(4-Methyl-Coumaryl-7-Amide) (Ac-DEVD-MCA) were obtained from Bachem (Torrance, CA, USA) and the Peptide Institute (Osaka, Japan), respectively.


Cell Culture and Conditions for Differentiation

Human monoblastic U937 cells (provided by the Japanese Cancer Research Resources Bank) were maintained in RPMI-1640 medium supplemented with 10% (v/v) fetal calf serum, 2 mM L-glutamine, (100 units/ml) penicillin G and 200 μg/ml streptomycin at 37°c under a humidified atmosphere of 5% (v/v) CO2. For U937 differentiation, cells (less than 2 x 105 cells/ml) were treated with IFN (100 units/ml) or RA (1 μM) for two days. These treated cells were denoted as U937IFN and U937RA, respectively.


Immunoblotting Analysis

Whole cells (1 x 106 per sample) were washed with ice-cold PBS and treated with 10% (w/v) TCA. After centrifugation, the precipitates were sonicated in 100μl of SDS-sample buffer and heat denatured. Samples (corresponding to 1 x 105 cells) were subjected to SDS-PAGE and transferred onto a PVDF membrane. The membrane was soaked in Tris-buffered saline (TBS) containing 20 mg/ml BSA for 1h at room temperature and incubated with antibodies overnight at 4°C. After removing excess antibodies, the membrane was incubated with an anti-rabbit antibody conjugated to alkaline phosphatase (Promega, Madison, WI, USA). Antibodies were visualized by the enzymatic reaction of alkaline phosphatase with 5-bromo-4-chloro-3-indolylphosphate (BCIP) and nitro blue tetrazolium (NBT). The specificities of the PARP antibody has been described previously [8].


Caspase Assay

After exposure to LPS or an anti-Fas antibody, cells were washed once with ice-cold PBS and then disrupted by sonication in 10mM Tris-HCl (pH 8.0) 1mM EDTA (TE buffer). Cell lysates were prepared by centrifugation and incubated in assay buffer [20mM Tris-HCl (pH 7.5), 0.5mM EDTA, 5mM 2-mercaptoethanol] at 37°C. After 15 min, 10μM Ac-DEVD-MCA was added and incubation was continued for an additional 15 min. Caspase activity was measured by the generation of 7-amino-4-methylcoumarin (AMC) (Excitation: 365nm and Emission: 460nm). One unit was defined as the amount of enzyme capable of generating one nmol of AMC in 1h.


Viability Assay

Following sensitization with LPS (100 ng/ml), cells were incubated at 37°C in a CO2 incubator. Viable cell numbers were estimated by an assay using MTT [9,10]. Briefly, cells (105 cells/100μl) were incubated with medium containing 0.5mg/ml MTT for 4h. The formazan product was solubilized with isopropanol containing 0.04N HCl, and absorbance at 590 nm was measured for each well. Viability was expressed as (OD590 of sensitized cells / OD590 of control cells) x 100.


Analysis of Cell Surface Molecules by Flow Cytometry

Cells (5 x 105) were washed with ice-cold PBS, resuspended in 100μl of PBS containing 3% (w/v) human γ-globulin (Jackson ImmunoResearch Laboratories, Inc.), and incubated for 10 min on ice. Cells were probed with saturating amounts of an anti-TLR4 MoAb or with isotype-matched nonbinding control MoAbs for 120 min at 4°C. After several washes with PBS, the MoAb bound to the cell surface was labeled with fluorescein isothiocyante (FITC)-conjugated goat anti-mouse Igs (TAGO, Inc.) for 60 min at 4°C. Analyses were then performed on a FACScan flow cytometer (Becton Dickinson, Mountainview, CA, USA). The results were calculated with CELLQuest software (Becton Dickinson).


RT-PCR Analysis

Total RNA was isolated from U937 cells using Isogen (Nippon Gene, Tokyo, Japan) according to the manufacturer’s instructions. For the RT reaction, 1μg of total RNA was reverse transcribed into cDNAs by using oligo(dT) [11] primers in a 25-μl reaction. MD-2 and β-actin cDNA were amplified from the cDNA mixture by PCR using the following primer sets: MD-2 sense 5’-atgttaccatttctgtttttttcc-3’, antisense 5’-ctaatttgaattaggttgg-3’; β-actin sense 5’-gaggagcaccccgtgctgctga-3’, antisense 5’-ctagaagcatttgctgtggacgatggaggggcc-3’. To quantify the level of mRNA expression, RT-PCR products separated on a 1% agarose gel were analyzed on an FLA-3000 (Fujifirm, Tokyo, Japan). ImageGauge software (Fujifirm) was used to compare the density of the products. Results are expressed as relative changes in RNA amounts that have been normalized to the amount of β-actin, which acted as an internal standard.


Antisense Oligonucleotide Experiment

The antisense and control oligonucleotides directed to knock down TLR4 expression were designed and manufactured by Biognosik, Germany. In experiments aimed at establishing the time course of oligonucleotide uptake by U937 cells, a fluorescein-labeled phosphorothioate oligonucleotide was added to the culture and incubated for various time durations ranging from 0-48h. The oligonucleotides (TLR4 antisense: 5’- cgaggcagacatcat -3’, control: 5’- gtccctatacgaacg -3’) were hound to be effective, and thus were delivered to cells by Oligofectamine (Invitrogen, Carlsbad, CA, USA) and Opti-Mem (Invitrogen) according to the manufacturer’s instructions. After transfection with the oligonucleotides, the cells were incubated with IFN at 37°C for 48h. The transfections had no detectable effect on cell differentiation.


Preparation of Recombinant Protein and Protein Transfection

The dominant negative form of FADD, a 1-79 amino acid residue deletion mutant, was amplified by RT-PCR using the forward primer: ccgctcgaggacgacttcgaggcgggg and the reverse primer: cgcggatccttatcgtcgtcgctgtctccgcttcttcctgccataggacgcttcggaggtagatgc. The 5’-terminal end of the reverse primer corresponded to the protein transduction motif TAT. The PCR fragment was cloned into an expression vector pIVEX2.4b. The TAT-containing recombinant protein was expressed using the Rapid Translation System (Roche diagnostics, Tokyo, Japan), according to the manufacturer’s instructions. Subsequently, recombinant protein was applied to a column of Ni-NTA agarose (Qiagen, Tokyo, Japan) and polymyxin B agarose (Sigma). After cells were kept in RPMI1640 with 2% serum for 1h, TAT-recombinant protein was added to cells to a final concentration of 0 to 3 μM, and the cells were incubated for 1h. Subsequently, apoptosis was induced by a cytotoxic anti-Fas antibody (50ng/ml) or by LPS (100ng/ml).


Statistical Analysis

Student’s t test was used to analyze significant differences. P values < 0.05 were regarded as significant.


U937 cells undergo changes in susceptibility to LPS-induced apoptosis upon differentiation. We examined whether U937 cells become susceptible to apoptosis in response to IFN treatment. Cell viability was assessed by an MTT assay. U937IFN cells treated with LPS showed a time-dependent loss of cell viability (Figure 1). The percentage of viable U937IFN cells was 65% after 24h of LPS stimulation, and this was similar in cells treated with an anti-Fas antibody (55% in 24h; Figure 1). However, the viability of U937 and U937RA cells did not decrease, even after cells were exposed to LPS.

Since the MTT assay cannot distinguish between different types of cell death, apoptosis or non-apoptotic cell death, the morphological features of the LPS-mediated cell death were examined. U937 cells were exposed to LPS for 9h and stained with hematoxylin. Whereas U937 and U937RA cells showed no apparent changes, the U937IFN cells exhibited cytoplasmic shrinkage and nuclear condensation (Figure 2A). These morphological features were similar to those seen in cells treated with the anti-Fas antibody (Figure 2A)

The activity of caspase in LPS-exposed cells was also examined. To detect caspase-3/-7 activity, we assessed apoptotic cleavage of the 116 KDa poly(ADP-ribose)polymerase (PARP), one of substrates of the executioner caspase, into an 85KDa fragment by immunoblotting analysis. Similar to the effect of treating with the anti-Fas antibody, LPS induced proteolysis of PARP in U937IFN cells (Figure 2B). In contrast to U937IFN cells, LPS failed to induce cleavage of PARP in U937 or U937RA cells (Figure 2B). The caspase activity in the cytoplasmic fraction of U937IFN cells was also assessed by using the synthetic peptide substrate Ac-DEVD-MCA. Z-VAD-fmk-sensitive caspase activity in U937IFN cells increased threefold at 6h and by a factor of eight at 9h (Figure 2C). These results suggest that U937 cells have altered susceptibility to apoptosis caused by LPS, depending on their differentiation state.

IFN enhances expression of the LPS receptor. U937 cells differentiate into CD11b positive cells after pretreatment with IFN or RA. However, the expression level of this marker protein is different in response to IFN or RA treatment [8]. It appears that the two reagents lead U937 cells to different states. It is conceivable that the degree of susceptibility to apoptosis is defined by some distinct features of these cells. We decided to investigate alterations of LPS receptor expression among three differentiation states of U937 cells. Using an anti-TLR4 antibody and flow cytometric analysis, the amount of cell surface TLR4 was assessed. As shown in (Figure 3A), exposure of U937 cells to IFN increased TLR4 expression on the cell surface. This indicated enhanced expression of TLR4 at the surface of U937IFN cells (average relative mean fluorescence intensity (MFI), 97), with a 4.5-fold increase in MFI compared with U937 cells (average relative MFI, 21.5).Since TLR4 forms a complex with MD-2, then is translocated to the cell surface where it recognizes LPS, we analyzed the expression level of MD-2. Because we did not have methods to quantify the MD-2 protein, the MD-2 mRNA level was compared by reverse transcription-polymerase chain reaction (RT-PCR). U937IFN cell mRNA expression was double that of the other cells (Figure 3B). These results suggest that susceptibility to apoptosis is closely related to the expression level of the LPS receptor.

LPS receptor triggers apoptosis in the U937IFN cells. Since U937IFN cells showed a large amount of the LPS receptor, we tried to transfect the gene of TLR4 in order to express this receptor in undifferentiated U937 cells. However, transfectants were not established. Therefore, U937IFN cells were transfected with an antisense oligonucleotide (ASO) to reduce the TLR4 level. As shown in (Figure 4A), pretreatment with 250nM ASO reduced the TLR4 level on the surface of U937IFN cells. This expression level was similar to that of undifferentiated U937 cells. In contrast, transfection with control oligonucleotide (CTO) into U937IFN cells did not alter the TLR4 level (Figure 4A). When U937IFN cells transfected with ASO were treated with LPS, cleavage of PARP was not detected in the cell lysate (Figure 4B). ASO-transfected U937IFN cells also did not exhibit any morphological changes when cells were exposed to LPS (Figure. 4C). In contrast, LPS induced limited digestion of PARP, nuclear condensation and cytoplasmic shrinkage in the CTO-transfected U937IFN cells (Figure 4B and 4C). Transfection with ASO into U937IFN cells did not prevent morphological changes induced by an anti-Fas antibody (Figure 4C).

It has been reported that an anti-TLR4 monoclonal antibody (MoAb) blocks cytokine production in response to LPS [12]. This indicates that the anti-TLR4 MoAb antagonizes LPS-signaling. Thus, we examined whether the anti-TLR4 MoAb prevents LPS-mediated apoptosis. When the anti-TLR4 MoAb (3μg/ml) was added to the U937IFN cells culture prior to LPS, Ac-DEVD-MCA-hydrolysis activity of the cell lysate decreased to approximately 40% that of the cells treated with LPS (Figure 5A). Control MoAb did not block activation of caspase. Addition of 1μg/ml and 3μg/ml of anti-TLR4 MoAb reduced caspase activity by 40% and 65%, respectively, in the lysate prepared from LPS-treated cells (Figure 5B). Immunoblot analysis showed that PARP hydrolysis induced by LPS was also inhibited by the anti-TLR4 MoAb (Figure 5C). However, the anti-TLR4 MoAb did not prevent Fas-mediated cleavage of PARP (Figure 5C), indicating that apoptosis induced by LPS was mediated by the LPS receptor.

The death ligand and death receptor are not activated during LPS-induced apoptosis. It is conceivable that LPS induces apoptosis through the autocrine production of tumor necrosis factor-α (TNF-α). To investigate this question, we first decided the amount of TNF-α (100units/ml) that was sufficiently able to induce apoptosis, and then determined the requisite concentration (100-300 ng/ml) of anti-TNF-α antibody to neutralize TNF-α(data not shown). In the presence of an anti-TNF-α antibody, LPS induced cleavage of PARP (Figure. 6A left). When we carried out a similar experiment utilizing a neutralizing anti-Fas antibody, PARP cleavage was not blocked (Figure 6A right). The cytoplasmic adaptor molecule FADD (Fas-associated death domain containing protein) binds to the death domain of the death receptor and transmits apoptotic signals. The recombinant carboxy terminal portion of FADD functions as a loss of function molecule that prevents receptor-mediated apoptosis [13]. To prevent death receptor signals, we tried to transport this FADD mutant into cells. The HIV TAT sequence, corresponding to amino acids 49 to 57 of the TAT protein, is known to facilitate the delivery of proteins into mammalian cells in a concentration-dependent manner [14-16]. A fusion protein combining a FADD mutant (FADD D/N) and the TAT sequence was prepared and transfected into U937IFN cells. The amount of intracellular FADD D/N increased in a concentration-dependent manner (Figure 6B bottom). Limited digestion of PARP induced by the anti-Fas antibody was prevented at FADD D/N concentrations of 1 and 3μM (Figure 6B top). However, LPS induced cleavage of PARP even though cells were transfected with 3μM of the recombinant protein (Figure 6B middle). When cells were stained with hematoxylin after exposure to LPS, the FADD D/N transfected cells showed nuclear fragmentation induced by LPS but not by an anti-Fas antibody (Figure 6C).These results suggest that LPS induces apoptosis independent of the activities of death ligands and death receptors.


In this study, we investigated the relationship between differentiation of U937 cells and their changing susceptibility to apoptosis in response to LPS. Our most important finding was that IFN induced expression of the LPS receptor on U937 cells, and the increase in the amount of the LPS receptor was closely related to its increased susceptibility to LPS-induced apoptosis. This represents the first evidence that differentiation in response to IFN increases the susceptibility of U937 cells susceptibility to LPS-mediated apoptosis.

It has been reported that IFN induces the increased cell-surface expression of death receptors and their ligands, such as Fas and Fas ligand [17], and that LPS promotes TNF-α production [18,19]. Thus, IFN and LPS might theoretically also mediate apoptosis by employing the pathways triggered by Fas or by the TNF receptor. In U937IFN cells, however, antibodies against Fas or TNF-? had no effect on LPS-induced apoptosis. Furthermore, in the case of death receptor-mediated apoptosis, the adaptor molecule FADD plays an important role in the formation of DISC and the activation of caspase-8, to initiate the cascade of apoptosis [13,20]. Our data showed that LPS induced apoptosis in U937IFN cells, even when the cells were pretreated with a FADD loss of function mutant that prevents Fas-mediated apoptosis (Figure 6B and 6C). These results suggest that the mechanism of LPS-triggered apoptosis is distinct from the typical death receptor-mediated apoptosis.

U937 cells alter the susceptibility to apoptosis caused by the Fas ligand and by TNF-α when cells are pretreated with IFN or RA [1]. This change of apoptotic susceptibility, which accompanies by differentiation, is caused by changes in the expression level of Fas. IFN induces expression of Fas [3,4], whereas RA reduces the expression of this death receptor [2]. In this study, following induction of cell differentiation the U937 cells also alter their susceptibility to LPS-induced apoptosis. To elucidate the reason why U937IFN cells become susceptible to LPS-induced apoptosis, we focused on the expression level of the LPS receptor, which consists of TLR4 and MD-2. IFN treatment enhances expression of TLR4 and MD-2 in U937 cells (Figure 3). The increased expression of TLR4 and MD-2 that we observed in response to IFN is consistent with previous studies that show IFN stimulates TLR4 and MD-2 expression in human mononuclear phagocytes and HL-60 monocytic cells [21-23].It has been reported that IRF (interferon regulatory factors) activate the promoter region of TLR4 [24,25]. A similar transcription mechanism may be involved in enhancing the expression of the LPS receptor complex in U937IFN cells.

Because IFN induced a high expression level of the LPS receptor as well as enhanced susceptibility to apoptosis, we investigated why increased sensitivity to LPS-induced apoptosis required either pretreatment with IFN or expression of the LPS receptor. The TLR4 gene was transfected into undifferentiated U937 cells, but this did not result in establishment of transfectants. Therefore, the reduction of TLR4 expression by transfection of antisense oligonucletides was carried out in U937IFN cells. U937IFN cells with low levels of TLR4 expression resist LPS-induced apoptosis (Figure 4). Furthermore, when these cells were cultured with an anti-TLR4 MoAb, the caspase activity caused by LPS was reduced in a concentration-dependent manner (Figure 5B). Our results showed that the neutralization antibody binds to TLR4 and restricts its activity, indicating that active TLR4 is reduced by this antibody,similar to the effect of an ASO. Consequently, we concluded that increase of LPS receptor levels on cell surfaces induced by IFN is necessary for increased susceptibility to LPS-induced apoptosis.

Indeed, U937IFN cells acquired susceptibility to LPS-induced apoptosis (Figure 1 and 2). Although Fas transmits death signals, the LPS receptor transmits primarily cell activation signals, rather than death signals. Therefore, analysis of LPS-induced apoptosis is performed in the presence of mRNA or protein synthesis inhibitors [26-28]. However, U937IFN cells showed apoptosis without these inhibitors. This result indicates that the fate of U937IFN cells switches from survival to death. These are two possible interpretations of this observation. The first explanation is that cells can only respond to a limited number of signals from the LPS receptor. When numerous signals stimulate the cells, the intracellular cascade automatically shifts to an apoptotic pathway. A second explanation is that proapoptotic factors induced by IFN divert signals from cell survival pathways to apoptotic pathways. Both interpretations are consistent with the result that the increased levels of LPS receptors in response to IFN transmit apoptotic signals, and that reduction or neutralization of the LPS receptor results in resistance against LPS-induced apoptosis.

In conclusion, U937 cells pretreated with IFN showed increased susceptibility to LPS-induced apoptosis. IFN stimulated expression of TLR4 and MD-2. These results suggest that the expression level of the LPS receptor is closely related to cellular susceptibility to LPS-induced apoptosis. From this analysis of a monocyte/macrophage differentiation model using U937 cells, we conclude that LPS-induced monocyte/macrophage apoptotic responses may play an important role in the regulation of innate immune responses.


This work was supported in part by grants from the Ministry of Education, Culture, Sport, Science and Technology of Japan.


1) Kikuchi H, Iizuka R, Sugiyama S, Gon G, Mori H, et al. (1996) Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells. J Leukoc Biol 60: 778-783.

2) Salih HR, Starling GC, Brandl SF, Pelka-Fleischer R, Haferlach T, et al. (2002) Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expression. Br J Haematol 117: 76-85.

3) Kim MS, Lee J, So HS, Lee KM, Jung BH, et al. (2001) Gamma-interferon (IFN-gamma) augments apoptotic response to mistletoe lectin-II via upregulation of Fas/Fas L expression and caspase activation in human myeloid U937 cells. Immunopharmacol Immunotoxicol 23: 55-66.

4) Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, et al. (1996) Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229: 21-26.

5) Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, Robledo G, Pedroso M, et al.(2001) Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism. J Biol Chem 276: 17779-17787.

6) Nonaka T, Kuwae A, Sasakawa C, Imajoh-Ohmi S (1999) Shigella flexneri YSH6000 induces two types of cell death, apoptosis and oncosis, in the differentiated human monoblastic cell line U937. FEMS Microbiol Lett 174: 89-95.

7) Nonaka T, Kuwabara T, Mimuro H, Kuwae A, Imajoh-Ohmi S (2003) Shigella-induced necrosis and apoptosis of U937 cells and J774 macrophages. Microbiology 149: 2513-2527.

8) Niikura Y, Nonaka T, Imajoh-Ohmi S (2002) Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP). J Biochem (Tokyo) 132: 53-62.

9) Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942.

10) Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946.

11) Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, et al. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4: 1449-1452.

12) Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, et al. (2000) Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun 268: 172-177.

13) Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.

14) Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, et al. (2000) Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 275: 11993-12002.

15) Gallouzi IE, Steitz JA (2001) Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294: 1895-1901.

16) Sumimoto S, Ishigami T, Horiguchi Y, Yonehara S, Kanazashi S, et al. (1994) Anti-Fas antibody induces different types of cell death in the human histiocytic cell line, U937, and the human B cell line, B104: the role of single-strand DNA breaks and poly (ADP-ribosyl)ation in cell death. Cell Immunol 153: 184-193.

17) Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, et al. (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186: 1831-1841.

18) Ha DK, Leung SW, Fung KP, Choy YM, Lee CY (1985) Role of lipid A of endotoxin in the production of tumour necrosis factor. Mol Immunol 22: 291-294.

19) Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, et al. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795-7798.

20) Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, et al. (2002) Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99: 3427-3431.

21) Mita Y, Dobashi K, Nakazawa T, Mori M (2001) Induction of Toll-like receptor 4 in granulocytic and monocytic cells differentiated from HL-60 cells. Br J Haematol 112: 1041-1047.

22) Mita Y, Dobashi K, Shimizu Y, Nakazawa T, Mori M (2001) Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol Lett 78: 97-101.

23) Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, et al. (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277: 20431-20437.

24) Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, et al. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 275: 9773-9781.

25) Choi KB, Wong F, Harlan JM, Chaudhary PM, Hood L, et al. (1998) Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J Biol Chem 273: 20185-20188.

26) Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK, et al. (2001) A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 276: 14924-14932.

27) Bannerman DD, Tupper JC, Erwert RD, Winn RK, Harlan JM (2002) Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1. J Biol Chem 277: 8048-8053.

28) Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S, et al. (1995) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem Biophys Res Commun 217: 1070-1077.